Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Luffa acutangula extract** is a crude or standardized extract derived from various parts (primarily fruit, seeds, flowers, and aerial parts) of the plant Luffa acutangula, a member of the Cucurbitaceae family. Traditionally used in Indian and Southeast Asian medicine, the extract contains a complex mixture of phytochemicals including flavonoids (e.g., apigenin-7-glucoside, luteolin-7-glucoside), saponin triterpenes (notably acutosides A-G), anthraquinones, fatty acids, proteins, and a variety of volatile organic compounds, phenolic acids, and essential amino acids[1][2]. Pharmacological activities demonstrated in preclinical models include **antidiabetic, hepatoprotective, antiulcer, anticancer, antihyperlipidemic, antioxidant, antimicrobial, immunomodulatory, CNS depressant, analgesic, and anti-inflammatory actions**[1][3]. The mechanisms thought to underlie these activities include free radical scavenging, modulation of metabolic enzymes, and potential immunomodulation, but precise molecular targets are still under investigation. Clinical efficacy and safety remain incompletely established, with most evidence coming from traditional use and animal or in vitro studies[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on luffa acutangula extract.